Nuclear Medicine and Biology
Volume 34, Issue 8 , Pages 955-960 , November 2007

Decreased [18F]fluoro-2-deoxy-d-glucose incorporation and increased glucose transport are associated with resistance to 5FU in MCF7 cells in vitro

  • Tim A.D. Smith

      Affiliations

    • PET Unit, Department of Biomedical Physics, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 01224 553481.
    • ,
  • Rituka I. Sharma

      Affiliations

    • PET Unit, Department of Biomedical Physics, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
    • ,
  • Weiguang G. Wang

      Affiliations

    • Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
    • School of Applied Sciences, University of Wolverhampton, City Campus-South, Wolverhampton WV1 1SB, UK
    • ,
  • Andy E. Welch

      Affiliations

    • PET Unit, Department of Biomedical Physics, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
    • ,
  • Lutz F. Schweiger

      Affiliations

    • PET Unit, Department of Biomedical Physics, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK
    • ,
  • Elaina S.R. Collie-Duguid

      Affiliations

    • Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, UK

Received 29 June 2007 ,Revised 10 July 2007 ,Accepted 12 July 2007.

References 

  1. Goldie JH. Drug resistance in cancer: a perspective. Cancer Metastasis Rev. 2001;20:63–68
  2. Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007;274:1393–1418
  3. Smith TAD, Sharma RI, Thompson AM, Paulin FEM. Tumor F-18-FDG incorporation is enhanced by attenuation of p53 function in breast cancer cells in vitro. J Nucl Med. 2006;47:1525–1530
  4. Caraco C, Aloj L, Chen LY, Chou JY, Eckelman WC. Cellular release of [F-18]2-fluoro-2-deoxyglucose as a function of the glucose-6-phosphatase enzyme system. J Biol Chem. 2000;275:18489–18494
  5. Gambhir SS, Czernin J, Schwimmer J, Silverman DHS, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. J Nucl Med. 2001;42:1S–93S
  6. El-Khoueiry AB, Lenz HJ. Should continuous infusion 5-fluorouracil become the standard of care in the USA as it is in Europe?. Cancer Invest. 2006;24:50–55
  7. Colozzaa M, de Azambuja E, Cardoso F, Bernard C, Piccart MJ. Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era. Oncologist. 2006;11:111–125
  8. Mauritz R, van Groeningen CJ, Smid K, Jansen G, Pinedo HM, Peters GJ. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancer. Int J Cancer. 2007;120:2609–2612
  9. Wang WG, Cassidy J, O'Brien V, Ryan KM, Collie-Duguid E. Mechanistic and predictive profiling of 5-fluorouracil resistance in human cancer cells. Cancer Res. 2004;64:8167–8176
  10. Miccoli L, Oudard S, Sureau F, Poirson F, Dutrillaux B, Poupon MF. Intracellular pH governs the subcellular distribution of hexokinase in a glioma cell line. Biochem J. 1996;313:957–962
  11. Reyes AM, Bustamante F, Rivas CI, Ortega M, Donnet C, Rossi JP, et al. Nicotinamide is not a substrate of the facilitative hexose transporter GLUT1. Biochemistry. 2002;41:8075–8081
  12. Smith TAD. The rate-limiting step for tumor [F-18] fluoro-2-deoxy-d-glucose (FDG) incorporation. Nucl Med Biol. 2001;28:1–4
  13. Torizuka T, Zasadny KR, Recker B, Wahl RL. Untreated primary lung and breast cancers: correlation between F-18 FDG kinetic rate constants and findings of in vitro studies. Radiology. 1998;207:767–774
  14. Shin YK, Yoo BC, Chang HJ, Jeon E, Hong SH, Jung NS, et al. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Cancer Res. 2005;65:3162–3170
  15. Hakata T, Ito K, Horie T. Enhanced absorption of 3-O-methyl glucose following gastrointestinal injury induced by repeated oral administration of 5-FU in mice. J Pharm Sci. 2005;94:1713–1722
  16. Hwang JT, Ha J, Park OJ. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Commun. 2005;332:433–440
  17. Engles JM, Quarless SA, Mambo E, Ishimori T, Cho SY, Wahl RL. Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy. J Nucl Med. 2006;47:603–608
  18. Smith TAD. Facilitative glucose transporters in human cancer tissue. Br J Biomed Sci. 1999;56:285–292
  19. Airley RE, Phillips RM, Evans AE, Double J, Burger AM, Feibig HH, et al. Hypoxia-regulated glucose transporter Glut-1 may influence chemosensitivity to some alkylating agents: results of EORTC (First Translational Award) study of the relevance of tumour hypoxia to the outcome of chemotherapy in human tumour-derived xenografts. Int J Oncol. 2005;26:1477–1484
  20. Cloherty EK, Heard KS, Carruthers A. Human erythrocyte sugar transport is incompatible with available carrier models. Biochemistry. 1996;35:10411–10421
  21. Martin HJ, Kornmann F, Fuhrmann GF. The inhibitory effects of flavonoids and antiestrogens on the Glut1 glucose transporter in human erythrocytes. Chem-Biol Interact. 2003;146:225–235
  22. Fuhrmann GF, Derdenne S, Frenking G. Phloretin keto-enol tautomerism and inhibition of glucose transport in human erythrocytes (including effects of phloretin on anion transport. Biochem Biophys Acta. 1992;1110:105–111
  23. Blodgett DM, Carruthers A. Conventional transport assays underestimate sugar transport rates in human red cells. Blood Cells Mol Dis. 2004;32:401–407
  24. Csala M, Banhegyi G, Benedetti A. Endoplasmic reticulum: a metabolic compartment. FEBS Lett. 2006;580:2160–2165
  25. Chung JH, Cho KJ, Lee SS, Baek HJ, Park JH, Cheon GJ, et al. Overexpression of Glut1 in lymphoid follicles correlates with false-positive 18F-FDG PET results in lung cancer staging. J Nucl Med. 2004;45:999–1003

PII: S0969-8051(07)00187-4

doi: 10.1016/j.nucmedbio.2007.07.007

Nuclear Medicine and Biology
Volume 34, Issue 8 , Pages 955-960 , November 2007

Article Tools

* Image Usage & Resolution